Clinical Trial

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028

USA News Group News Commentary  Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. 17, 2025 /PRNewswire/ -- According to…

11 months ago

Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule

SAN DIEGO, CA / ACCESS Newswire / January 17, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company"), today announced…

11 months ago

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Design lock for ASIC microchip follows successful completion of in vivo preclinical and extensive bench testing Manufacturing of ASIC microchip…

11 months ago

First FDA-Approved Mesenchymal Stromal Cell Therapy Ushers in a New Era of Regenerative Medicine

Transformative Scientific Breakthrough Pioneered by Spencer Trask & Co. Venture Osiris Therapeutics NEW YORK, Jan. 16, 2025 /PRNewswire/ -- The…

11 months ago

Onco-Innovations’ Licensed Technology Shown in Study to Successfully Prevent Regeneration of Cancer Cells

VANCOUVER, BC / ACCESS Newswire / January 16, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased…

11 months ago

Transforming Cancer Care: ONCO and Inspirata Collaborate to Leverage AI/NLP for Enhanced Registry Solutions

TAMPA, Fla., Jan. 16, 2025 /PRNewswire/ -- ONCO Inc. ("ONCO") and Inspirata Inc. ("Inspirata") have announced a strategic partnership to…

11 months ago

Zero Candida Announces Successful Listing on Frankfurt Stock Exchange and Details of Investor Webinar

VANCOUVER, BC, Jan. 16, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (FSE: 9L2) (the "Company" or "ZCT"), an…

11 months ago

PhaseV Advances Machine Learning-Driven Lupus Research in New Toronto Collaboration

Collaboration Leveraging University Health Network's Expertise to Evaluate PhaseV's Machine Learning (ML) Platform to Identify Causes of Lupus Progression and Improve…

11 months ago

Emmes Group® names Germaine Gross Chief Commercial Officer of Emmes® Biopharma

Strategic hire underscores Emmes Group's growth and commitment to biopharma market ROCKVILLE, Md., Jan. 16, 2025 /PRNewswire/ -- Emmes Group®,…

11 months ago